NCT00221611View on ClinicalTrials.gov

Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

August 31, 2006

Conditions

Cerebral Palsy

Interventions

DRUG

Administration of intrathecal baclofen

Trial Locations (1)

9000

University Hospital Ghent, Ghent

All Listed Sponsors

lead

University Hospital, Ghent

OTHER

NCT00221611 - Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity | Biotech Hunter | Biotech Hunter